Astrid Pozet

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Erratum It has come to our attention that there is an error in one of the author names for this article [1]. The author name Patrick Manckoundia was incorrectly spelt as Patrick Mankoundia. The original article has now been updated. Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty. permits unrestricted use,(More)
BACKGROUND Medical progress and the lifestyle modification have prolonged life expectancy, despite the development of chronic diseases. Support and care for older subjects are often provided by a network of informal caregivers composed of family, friends and neighbors, who are essential in helping older persons to continue living at home. It has been shown(More)
BACKGROUND Frailty is highly prevalent in elderly people. While significant progress has been made to understand its pathogenesis process, few validated questionnaire exist to assess the multidimensional concept of frailty and to detect people frail or at risk to become frail. The objectives of this study were to construct and validate a new(More)
The combination of cisplatin or carboplatin and etoposide is the standard treatment for certain poorly differentiated neuroendocrine cancers, such as small-cell lung cancer. The aim of this study was to assess the efficacy and tolerability of the carboplatin-etoposide regimen in metastatic castra-tion-resistant prostate cancer (mCRPC). A total of 27(More)
  • 1